NYSE · Health Information Services · USD
Veeva Systems Inc. (VEEV) Stock Analysis
Veeva Systems Inc. (VEEV) is a Health Information Services stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
VEEV Key Statistics
As of Oct 21, 2026Trading
- Open
- $317.01
- Previous Close
- $318.67
- Day's Range
- 316.08–322.99
- 52-Week Range
- 148.05–322.99
- Volume
- 1.43M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.93
Valuation
- Market Cap
- $51.90B
- P/E Ratio
- 52.55
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 31.27
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.23
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 15.01
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 6.10
Financials (FY)
- Revenue (FY)
- $3.20B+16.34%
- Net Income (FY)
- $908.91M+27.27%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 29.35%
- Shares Outstanding
- 161.91M
- 1-Year Return
- +10.60%
Dividend and dates
- Earnings Date
- November 25, 2026estimated
- Avg Volume
- 1.71M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, VEEV closed at $320.55, +10.60% over 1 year.
Veeva Systems Inc. (VEEV) has a market capitalization of $51.90B.
In fiscal 2025, VEEV reported revenue of $3.20B.
VEEV Stock Return by Calendar Year
Veeva Systems Inc. (VEEV) 10-year return: what $10,000 became
- 1 year
- $10,000 $11,060
- +10.60%
- 5 years
- $10,000 $9,855
- −1.45%
- 10 years
- $10,000 $82,595
- +725.95%
If you had invested $10,000 in Veeva Systems Inc. (VEEV) 10 years ago, at the close on October 21, 2016, it would have been worth $82,595 at the close on October 21, 2026: +725.95% in total, +23.51% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +43.60% |
| 2025 | +6.17% |
| 2024 | +9.21% |
| 2023 | +19.30% |
| 2022 | −36.83% |
| 2021 | −6.16% |
| 2020 | +93.55% |
| 2019 | +57.48% |
| 2018 | +61.58% |
| 2017 | +35.82% |
| 2016 (partial year) | +6.29% |
As of October 21, 2026.
VEEV Revenue and Earnings by Fiscal Year
FY ends January| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $3.20B | $908.91M | 28.4% |
| 2024 | $2.75B | $714.14M | 26.0% |
| 2023 | $2.36B | $525.71M | 22.2% |
| 2022 | $2.16B | $487.71M | 22.6% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $3.20B | $2.41B | $916.37M | $908.91M | 28.4% |
| 2024 | $2.75B | $2.05B | $691.44M | $714.14M | 26.0% |
| 2023 | $2.36B | $1.69B | $429.33M | $525.71M | 22.2% |
| 2022 | $2.16B | $1.55B | $459.09M | $487.71M | 22.6% |
Annual figures as reported, in the company's reporting currency. As of January 31, 2026.
VEEV Valuation vs Health Information Services Median
Median of 44 stocks| Metric | VEEV | Health Information Services median | vs median |
|---|---|---|---|
| P/E | 52.55 | 46.54 | 13% above |
| P/S ratio | 15.01 | 2.31 | 6.5x the median |
| Profit margin | 29.35% | −7.55% | 36.9 pts above |
Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
YahooBarclays Maintains Overweight on Veeva Systems, Raises Price Target to $360
BenzingaVeeva Systems' Research and Development Growth Tracking to Plan, Oppenheimer Says
YahooIs Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
YahooVeeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
YahooVeeva to Host Virtual Investor Day on November 5, 2026
Yahoo
All 20 articles ↓Show fewer ↑
Is Veeva Systems (VEEV) Quietly Redefining Clinical Tech Moats With IQVIA Deal And Basics Uptake?
YahooVeeva Systems (VEEV) Becomes Default Clinical Software Across A Major Research Partner
YahooVeeva Stock Breaks Out As Big Money Grabs Exposure To The AI Software Play
YahooVEEV Expands IQVIA Partnership With Clinical Operations Software Suite
YahooGlobal Life Sciences IT Market Opportunities and Strategies to 2035 | Capitalize on AI, Cloud and Bioinformatics as IQVIA, Oracle, Accenture, Veeva Systems and SAP Target $82.24B
YahooVeeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
YahooVeeva Systems (VEEV) Stock Trades Up, Here Is Why
Yahoo$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today
BenzingaVeeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms
YahooIQVIA Selects Veeva Clinical Operations Applications
YahooIQVIA Selects Veeva Clinical Operations Applications
YahooIQVIA Expands Partnership Veeva Systems On Enterprise Standard Applications That Will Be Used Across IQVIA Clinical Development Studies
BenzingaVertical Software Stocks Q2 Results: Benchmarking Veeva Systems (NYSE:VEEV)
YahooIBD Stock Of The Day Veeva Flirts With A Breakout. Can It Catch Up To Salesforce?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Health Information Services Stocks
BrightSpring Health Services, Inc.
$12.40B
TEMTempus AI, Inc.
$12.23B
HNGEHinge Health, Inc.
$9.04B
HQYHealthEquity, Inc.
$8.10B
DOCSDoximity, Inc.
$5.99B
WAYWaystar Holding Corp.
$5.53B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B








